Keros Therapeutics
KROS
$57.30
Share price
-0.73%
Change (1 day)
24.38%
Change (1 year)
Categories
Keros Therapeutics (KROS) Fails to deliver data
Key failure to deliver metrics for Keros Therapeutics:
- Last SEC data release: 2024-04-12
- Last 15 days FTD volume: $0.03 M
- Last 3 months FTD volume: $1.69 M
- Last year FTD volume: $3.46 M
Failures to deliver for Keros Therapeutics (KROS) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Keros Therapeutics (KROS) - since 2020
Volume in USD (price x number of shares), data since 2020Keros Therapeutics (KROS) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $1.74 M | -73.75% |
| 2023 | $6.64 M | 3.04% |
| 2022 | $6.45 M | -72.87% |
| 2021 | $23.77 M | 128.32% |
| 2020 | $10.41 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $2.25 M | $6.85 M | 🇺🇸 USA |